Israel Active

Israel’s ELGAN (see previously) has been awarded a $2.5 million grant by the European Innovation Council (EIC). It will help ELGAN clinically test its ELGN-GI oral formula for the treatment of intestinal malabsorption that prevents preterm infants from absorbing nutrients.

Doctors at Israel’s Sheba Medical Center have developed AISAP POCAD (AI Point of Care Assisted Diagnosis) to diagnose a patient’s cardiac problem As Soon As Possible. The AI system uses any manufacturer’s supplied combination of handheld ultrasound probe and digital tablet.

Israeli-founded Bionaut Labs (see previously) has safety-tested its micro robot containing a magnet, that can travel via spinal fluid, directly to the brain, to deliver therapy or perform surgery. It can also navigate to any part of the body. Bionaut plans to begin human trials in late 2024.

Israel’s Enzymit is developing enzymes to enable some life-changing chemical reactions (see videos). First, though, it has synthesized hyaluronic acid - a natural biopolymer used to heal eyes, wounds, inflammation, and more. This avoids the use of animal tissue or costly alternate processes.

Israeli biotech MemoryPlus has developed a peptide to block the interaction of proteins PTEN & PSD-95, that causes memory loss in Alzheimer’s patients. The disease makes excessive PTEN, which attacks PSD-95, weakening the brain’s synapses. The peptide also lowers PTEN levels.

Researchers at Israel’s Weizmann Institute have found that Erbitux - a therapy for colon and neck / head cancer - can also cure lung cancer in non-smokers with a mutated EGFR gene. They have also identified a biomarker to identify those patients.

Personally tailored treatments for cancer patients are well known. Now Tel Aviv University researchers propose a similar approach to fighting infections. Two immune markers in the blood indicate which medication and dosage can best fight the pathogen and repair the damage.

Israel’s Avertto won the 2023 Hebrew University Asper Prize. Most stroke patients do not reach the emergency room on time. Avertto’s system monitors blood flow to the brain, detects any changes and provides real-time alerts to enable timely treatment, thereby preventing strokes.

The Israeli nonprofit Start-Up Nation Central has announced a new initiative, Hospital2Hospital, to partner South Florida’s Baptist Health Innovations and Israel’s Sheba Medical Center’s ARC Innovation. Israeli startups will compete for a $75,000 grant to help launch in the US.

This brief video summarizes the successes of Israel’s leading hospital – Sheba Medical Center. It emphasizes Sheba’s ethos of innovation, compassion, and a commitment to a global well-being.  Advancing healthcare not only to Israelis, but to the citizens of the world.